ANTHEM-TIMI 32

ANTHEM-TIMI 32 assessed the efficacy and safety of anticoagulation with rNAPc2 in non-ST segment elevation acute coronary syndrome patients managed with an early invasive strategy in 203 patients with nSTE-ACS undergoing early catheterization. MAIN RESULTS: Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial J Am Coll Cardiol. … Continue reading ANTHEM-TIMI 32